Organ Growth

Juvenescence (2): “It’s all about prevention, and that’s incredibly disruptive”

Juvenescence's Greg Bailey on democratising healthcare, paradigm shifts and disruptive technologies. Yesterday we published the first part of our interview with Greg Bailey, CEO of...

Juvenescence (1): from strength to strength in R&D and investment firepower

Juvenescence's Greg Bailey on transformative scientific opportunities, immuno-resilience, modifying aging and funding. Continuing our series of interviews with our Advisory Panel members, we spoke to Greg...

All the way from regenerative research to commercialisation

We speak to the director of the Wake Forest Institute of Regenerative Medicine – a research organisation with a clear focus on commercialisation. Just on...

Hydrogel scaffold raises hopes for tissue regeneration

Wyss Institute hydrogel therapy can repair nerves, muscles and blood vessels. Naturally-occurring molecules VEGF and IGF-1 can enhance tissue regrowth and repair, but getting them...

Juvenescence CEO on near-term Longevity breakthroughs

We talk pipeline, trials, raising capital and public company challenges with Juvenescence's Dr Greg Bailey. Longevity.Technology: Longevity is growing as a distinct investment category and Thursday’s...

Fishing for regenerative therapies

Talking Longevity, indication expansion, killifish and regeneration with Dr Aric Rogers from the MDI Biological Laboratory. Nestled on the picturesque coastline of Maine, USA, the...

New imaging technique progresses organ growth

A new breakthrough has created transparent organs which could support improved organ growth and solve the global organ donation crisis. We often hear calls for...

Hormone producing organoids to halt age-related disease

JangoBio claims a scientific breakthrough in developing sustainable stem-cell based organoids for hormone restoration. Having recently closed a $2m seed round, researchers at JangoBio's Wisconsin...

Lab-grown muscle in heart transplant breakthrough

Japanese research team announces world-first. Lab-grown heart muscles created from induced pluripotent stem (iPS) cells successfully transplanted into a human: a new take on...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Xenotransplant pigs organs one-step closer

Scientists are moving closer to creating first human transplant organs from pigs. More than 100,000 people are on the organ transplant waiting list in the US...

Supporting research and organ growth. Literally

Manchester BIOGEL to start providing kits for tissue growth as the company scales-up in 2020. Another of the interesting companies we encountered at the 3D...

Healios to fast-track pluripotent stem cell therapy

Healios K.K. to bring its novel regenerative pluripotent stem cell treatments to market through accelerated Japanese approvals process. Stem cell pioneers Healios KK will use...

New hydrogel advances Longevity applications

Hydrogels have been used in everything from contact lenses to babies’ nappies. Now, scientists have made a breakthrough which could pave the way for...

Organoids will attract bigger investment in 2020

Mini organs set for maximum success as new models can be used to individualise cancer therapy. Organoids are three-dimensional bundles of cells grown in culture...

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Exclusive: Complex organoids from stem cells

Lab-grown organs similar to normal tissue and superior to previous structures. Scientists at the University of Würzburg recently announced they have successfully produced human tissues...

Novoheart and AstraZeneca develop heart in a jar

AstraZeneca and Novoheart have combined forces to develop a first of its kind model for a common, but much misunderstood form of heart failure. Pharma...

Rejuvenation: If I could turn back time …

Bioquark looks to nature for the answers to regeneration and rejuvenation. Last week, the BBC reported on the plight of axolotls in Mexico City, which...

LyGenesis raises $4m ahead of Phase 2a trials

New money for technology that uses lymph nodes as bioreactors to regrow functioning organs. LyGenesis, a biotechnology company focused on organ regeneration, announced that it...

Latest articles

Epigenetic regulation of protein homeostasis following DNA damage

Recent study identifies critical regulator of protein biosynthesis recovery and homeostasis required for Longevity. Unresolved DNA damage caused by intrinsic and environmental factors accumulates during...

Deep Longevity and Longenesis collaborate to clock aging

Start the clock to stop the clock – centralised data will aid Longevity research.  Deep Longevity, which engages in the development of explainable AI systems...

Big Brother approach to accelerate preclinical studies

Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies. A Danish start-up aims...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...